• 中文核心期刊要目总览
  • 中国科技核心期刊
  • 中国科学引文数据库(CSCD)
  • 中国科技论文与引文数据库(CSTPCD)
  • 中国学术期刊文摘数据库(CSAD)
  • 中国学术期刊(网络版)(CNKI)
  • 中文科技期刊数据库
  • 万方数据知识服务平台
  • 中国超星期刊域出版平台
  • 国家科技学术期刊开放平台
  • 荷兰文摘与引文数据库(SCOPUS)
  • 日本科学技术振兴机构数据库(JST)
Masoud Mohammad SALMANI Jumah, Xiao-Ping ZHANG, Antony JACOB Joe, Bao-An CHEN. Apigenin's anticancer properties and molecular mechanisms of action: Recent advances and future prospectives[J]. Chinese Journal of Natural Medicines, 2017, 15(5): 321-329. DOI: 10.3724/SP.J.1009.2017.00321
Citation: Masoud Mohammad SALMANI Jumah, Xiao-Ping ZHANG, Antony JACOB Joe, Bao-An CHEN. Apigenin's anticancer properties and molecular mechanisms of action: Recent advances and future prospectives[J]. Chinese Journal of Natural Medicines, 2017, 15(5): 321-329. DOI: 10.3724/SP.J.1009.2017.00321

Apigenin's anticancer properties and molecular mechanisms of action: Recent advances and future prospectives

  • Abstract: Cancer is a major health concern and leading burden on economy worldwide. An increasing effort is devoted to isolation and development of plant-derived dietary components as effective chemo-preventive products. Phytochemical compounds from natural resources such as fruits and vegetables are responsible for decreasing the risk of certain cancers among the consuming populations. Apigenin, a flavonoid phytochemical found in many kinds of fruits and vegetables, has been shown to exert significant biological effects, such as anti-oxidant, anti-inflammatory and most particularly anti-neoplastic properties. This review is intended to summarize the most recent advances in the anti-proliferative and chemo-preventive effects of apigenin in different cancer models. Analysis of the data from the studied cancer models has revealed that apigenin exerts its anti-proliferative effects through multiple and complex pathways. This guided us to discover some controversial results about the exact role of certain molecular pathways such as autophagy in the anticancer effects of apigenin. Further, there were cumulative positive evidences supporting the involvement of certain pathways such as apoptosis, ROS and DNA damage and repair. Apigenin possesses a high potential to be used as a chemosensitizing agent through the up-regulation of DR5 pathway. According to these preclinical findings we recommend that further robust unbiased studies should consider the possible interactions between different molecular pathways.

     

/

返回文章
返回